4th Quarter - Report
ARENTFOX SCHIFF LLP for FOUNDATION MEDICINE, INC.
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare program policy for regulatory approval and reimbursement for new oncology diagnostic technologies Reimbursement for new oncology diagnostic technologies generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN RENBERG | — |
Health Issues HCR
Food and Drug Administration regulatory policy generally and policy for approval of new oncology diagnostic technologies Drug pricing reforms generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN RENBERG | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| F. HOFFMANN-LA ROCHE AG | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.